Poly Medicure's Q4 FY 2025-26 Quarterly Results

Result Summary

• Poly Medicure Ltd reported a 6.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 18.7%.
• Its expenses for the quarter were up by 12.4% QoQ and 36.0% YoY.
• The net profit decreased 8.1% QoQ and decreased 29.2% YoY.
• The earnings per share (EPS) of Poly Medicure Ltd stood at 6.54 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Poly Medicure Ltd is a prominent player in the medical devices industry, known primarily for its comprehensive range of healthcare solutions. The company specializes in manufacturing and supplying a variety of medical devices, including infusion, blood management, surgery, and wound drainage systems. Operating in a highly competitive sector, Poly Medicure Ltd has established a significant presence both domestically and internationally. The company is committed to innovation and quality, consistently investing in research and development to expand its product offerings. As of the latest updates, no specific major developments have been provided in the data.

Revenue

In the fourth quarter of the fiscal year 2026, Poly Medicure Ltd reported a total income of ₹552.27 crores. This represents a quarter-over-quarter increase of 6.2% compared to the previous quarter, Q3FY26, where the total income was ₹519.92 crores. On a year-over-year basis, the total income grew by 18.7% from Q4FY25, which recorded a total income of ₹465.14 crores. This growth in revenue reflects the company's ability to enhance its sales performance over both the quarter and the year, indicating strong market demand for its products and services.

Profitability

For the same period, the profit before tax for Poly Medicure Ltd was ₹83.51 crores, marking a decline of 12.9% from the previous quarter's profit before tax of ₹95.93 crores. Compared to the same quarter in the previous year, Q4FY25, which had a profit before tax of ₹120.57 crores, there was a year-over-year decrease of 30.7%. The tax expense decreased both quarter-over-quarter and year-over-year, with values of ₹20.18 crores in Q4FY26, ₹26.80 crores in Q3FY26, and ₹31.02 crores in Q4FY25, corresponding to declines of 24.7% QoQ and 34.9% YoY. Consequently, the profit after tax stood at ₹65.04 crores in Q4FY26, down from ₹70.81 crores in Q3FY26 and ₹91.83 crores in Q4FY25, reflecting decreases of 8.1% and 29.2% respectively.

Operating Metrics

The earnings per share (EPS) for Poly Medicure Ltd in Q4FY26 was ₹6.54, which indicates a decline of 6.4% from the previous quarter's EPS of ₹6.99. Year-over-year, the EPS decreased by 26.7%, with Q4FY25 having an EPS of ₹8.92. In terms of expenses, the total expenses for Q4FY26 were ₹468.75 crores, showing an increase of 12.4% from ₹417.19 crores in Q3FY26. Year-over-year, total expenses grew by 36.0% compared to ₹344.57 crores in Q4FY25. Despite the revenue growth, the increase in expenses significantly impacted profitability metrics, resulting in lower earnings per share compared to both the previous quarter and the same quarter last year.